Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

sector : Health care and social assistance    tags : Biotechnology    save search

Vyant Bio Commences a Cash Preservation Plan Including a Reduction in Force
Published: 2023-02-03 (Crawled : 12:00) - biospace.com/
VYNT | $0.194 -8.51% 19K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: -4.17% H: 2.33% C: -15.91%


Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at Neuroscience 2022 Hosted by the Society for Neuroscience
Published: 2022-11-16 (Crawled : 23:00) - biospace.com/
VYNT | $0.194 -8.51% 19K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: -4.61% H: 0.0% C: -6.21%

platform
Vyant Bio Reports Third Quarter 2022 Results and Provides Strategic and Business Highlights
Published: 2022-11-15 (Crawled : 14:00) - biospace.com/
VYNT | $0.194 -8.51% 19K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: -0.99% H: 6.0% C: 1.33%

results
Viridian Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 14, 2022
Published: 2022-11-08 (Crawled : 20:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 0.11% H: 2.79% C: -0.21%

conference report therapeutics financial results
Vyant Bio to Present at the H.C. Wainwright Global Investment Hybrid Conference
Published: 2022-05-19 (Crawled : 13:20) - biospace.com/
VYNT | $0.194 -8.51% 19K twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 0.76% H: 4.55% C: 0.32%

conference
Viridian Therapeutics Announces FDA Clearance of Investigational New Drug Application to Initiate Clinical Development of VRDN-002, a Next Generation IGF-1R Antibody for the Treatment of Thyroid Eye Disease
Published: 2022-01-31 (Crawled : 15:00) - biospace.com/
VRDN | $14.59 -3.76% -3.91% 1.5M twitter stocktwits trandingview |
Health Care and Social Assistan...
| | O: 0.55% H: 10.04% C: 9.06%

vrdn-002 new drug treatment fda clearance eye application eye disease drug therapeutics disease fda clearance antibody
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.